Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea
· Delayed Price · Currency is KRW 1,050.00
-16.00 (-1.50%)
At close: Mar 28, 2025, 3:30 PM KST
Wonbiogen Revenue
In the year 2024, Wonbiogen had annual revenue of 30.44B KRW with 2.79% growth. Wonbiogen had revenue of 8.51B in the quarter ending December 31, 2024, with 15.42% growth.
Revenue
30.44B
Revenue Growth
+2.79%
P/S Ratio
1.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.44B | 824.93M | 2.79% |
| Dec 31, 2023 | 29.61B | 2.87B | 10.72% |
| Dec 31, 2022 | 26.75B | 9.03B | 50.94% |
| Dec 31, 2021 | 17.72B | 5.70B | 47.46% |
| Dec 31, 2020 | 12.02B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |